Drug Trial Radar · NCT05193409
A Phase 2 Study of BNC210 for the Acute Treatment of Social Anxiety Disorder
Last checked: Nov 19, 2026Latest source record: Mar 18, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
151
Actual
Start
Feb 2, 2022
Primary completion
Oct 10, 2022
Study completion Oct 17, 2022
Sponsor
- Lead sponsor
- Bionomics LimitedIndustry
- Sponsor type
- Industry
- First posted
- Jan 14, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess the effects of an acute dose of BNC210 compared to placebo on reducing anxiety provoked by a speaking challenge and measured using the Subjective Units of Distress Scale (SUDS) in patients with Social Anxiety Disorder (SAD).
Conditions
- Social Anxiety Disorder
Interventions
225 mg BNC210Drug
225 mg BNC210
675 mg BNC210Drug
675 mg BNC210
PlaceboDrug
Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline to the Average Subjective Units of Distress Scale (SUDS) Score of the 5-minute Performance Phase of a Public Speaking ChallengeTime frame: Assessed over a single visit: Baseline; and the Performance Phase (0,1,2,3,4,5 minutes) of the Public Speaking Challenge, conducted 1 hour post-dose.
Locations
15 sites in 1 country. Site status is shown where the registry gives one.
PREVAIL Study Clinical Trial Site
Beverly Hills, California
PREVAIL Study Clinical Trial Site
Encino, California
PREVAIL Study Clinical Trial Site
Glendale, California
PREVAIL Study Clinical Trial Site
New Haven, Connecticut
PREVAIL Study Clinical Trial Site
Lauderhill, Florida
PREVAIL Study Clinical Trial Site
Miami, Florida
PREVAIL Study Clinical Trial Site
Miami Lakes, Florida
PREVAIL Study Clinical Trial Site
Decatur, Georgia
PREVAIL Study Clinical Trial Site
Prairie Village, Kansas
PREVAIL Study Clinical Trial Site
Boston, Massachusetts
PREVAIL Study Clinical Trial Site
Princeton, New Jersey
PREVAIL Study Clinical Trial Site
Brooklyn, New York
PREVAIL Study Clinical Trial Site
Charlotte, North Carolina
PREVAIL Study Clinical Trial Site
Cincinnati, Ohio
PREVAIL Study Clinical Trial Site
Draper, Utah
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.